Study to Evaluate the Effect of ALS-008176 on Cardiac Repolarization Interval in Healthy Participants

Condition:   Healthy
Interventions:   Drug: ALS-008176;   Drug: Placebo;   Drug: Moxifloxacin
Sponsor:   Alios Biopharma Inc.
Recruiting - verified January 2017
News Type: